Stock Analysis on Net
Stock Analysis on Net

Boston Scientific Corp. (NYSE:BSX)

This company has been moved to the archive! The financial data has not been updated since May 4, 2023.

Common-Size Balance Sheet: Assets

Boston Scientific Corp., common-size consolidated balance sheet: assets

Microsoft Excel
Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Cash and cash equivalents 2.86 5.97 5.63 0.71 0.70
Trade accounts receivable, net 6.07 5.52 4.97 5.98 7.66
Inventories 5.75 5.00 4.39 5.17 5.55
Prepaid income taxes 0.81 0.64 0.63 0.64 0.77
Assets held for sale 0.00 0.00 3.68 0.00 0.00
Restricted cash and restricted cash equivalents 0.46 0.58 0.68 1.13 3.12
Derivative assets 0.71 0.70 0.43 0.34 0.58
Licensing arrangements 0.18 0.41 0.48 0.61 0.00
Other 0.89 0.79 0.85 0.80 0.69
Other current assets 2.25% 2.48% 2.44% 2.88% 4.39%
Current assets 17.74% 19.60% 21.75% 15.37% 19.06%
Property, plant and equipment, net 7.53 6.99 6.77 6.80 8.49
Goodwill 39.79 37.20 32.33 33.29 37.67
Other intangible assets, net 18.18 18.99 19.23 25.80 30.34
Deferred tax assets 12.14 12.85 13.68 13.73 0.41
Restricted cash equivalents 0.15 0.17 0.17 0.14 0.13
Operating lease right-of-use assets 1.19 1.35 1.49 1.10 0.00
Derivative assets 0.46 0.52 0.35 0.71 0.87
Investments 1.25 1.28 2.98 1.50 2.02
Licensing arrangements 0.21 0.35 0.71 1.09 0.00
Indemnification asset 0.53 0.00 0.00 0.00 0.00
Other 0.83 0.70 0.54 0.47 1.00
Other long-term assets 4.62% 4.37% 6.24% 5.00% 4.02%
Long-term assets 82.26% 80.40% 78.25% 84.63% 80.94%
Total assets 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).